dimethyl sulfoxide has been researched along with Weight Loss in 4 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the preventive effects of dimethyl sulfoxide (DMSO) on experimental hepatic fibrosis induced by dimethylnitrosamine (DMN) in rats." | 7.71 | Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. ( Enjoji, M; Kato, M; Kotoh, K; Nakamuta, M; Nakashima, Y; Nawata, H; Ohta, S; Sugimoto, R; Tada, S; Tsuruta, S, 2001) |
| "We studied the preventive effects of dimethyl sulfoxide (DMSO) on experimental hepatic fibrosis induced by dimethylnitrosamine (DMN) in rats." | 3.71 | Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. ( Enjoji, M; Kato, M; Kotoh, K; Nakamuta, M; Nakashima, Y; Nawata, H; Ohta, S; Sugimoto, R; Tada, S; Tsuruta, S, 2001) |
| " These data support the toxic accumulation of NAMI-A or of its products of transformation in the kidneys and stress the need of at least 14 days washout between two treatment cycles when the drug is given daily for 6 consecutive days." | 1.39 | Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice. ( Cocchietto, M; Pacor, S; Sava, G; Vadori, M; Vita, F; Zorzet, S, 2013) |
| "Dimethyl sulfoxide (DMSO) has been shown to reduce the accumulation of PrP(Sc) in scrapie-infected (ScN2a) cells, and to inhibit its aggregation in vitro." | 1.32 | Dimethyl sulfoxide delays PrP sc accumulation and disease symptoms in prion-infected hamsters. ( Avraham, I; Engelstein, R; Gabizon, R; Kahana, E; Shaked, GM, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vadori, M | 1 |
| Pacor, S | 1 |
| Vita, F | 1 |
| Zorzet, S | 1 |
| Cocchietto, M | 1 |
| Sava, G | 1 |
| Shaked, GM | 1 |
| Engelstein, R | 1 |
| Avraham, I | 1 |
| Kahana, E | 1 |
| Gabizon, R | 1 |
| Kumon, Y | 1 |
| Kim, SC | 1 |
| Tompkins, P | 1 |
| Stevens, A | 1 |
| Sakaki, S | 1 |
| Loftus, CM | 1 |
| Nakamuta, M | 1 |
| Ohta, S | 1 |
| Tada, S | 1 |
| Tsuruta, S | 1 |
| Sugimoto, R | 1 |
| Kotoh, K | 1 |
| Kato, M | 1 |
| Nakashima, Y | 1 |
| Enjoji, M | 1 |
| Nawata, H | 1 |
4 other studies available for dimethyl sulfoxide and Weight Loss
| Article | Year |
|---|---|
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cisplatin; Creatinine; Dimethyl Sulfoxide; | 2013 |
Dimethyl sulfoxide delays PrP sc accumulation and disease symptoms in prion-infected hamsters.
Topics: Animals; Brain; Cricetinae; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Injections, Intrap | 2003 |
Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia.
Topics: Analysis of Variance; Animals; Brain Edema; Cerebrovascular Circulation; Dimethyl Sulfoxide; Follow- | 2000 |
Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
Topics: Animals; Body Weight; Cell Line; Cells, Cultured; Chemical and Drug Induced Liver Injury; Collagen T | 2001 |